Anti-NMDA receptor encephalitis presenting as new onset refractory status epilepticus in COVID-19

Seizure. 2020 Oct:81:18-20. doi: 10.1016/j.seizure.2020.07.006. Epub 2020 Jul 15.

¹ Neurology Unit, Ospedale Ramazzini di Carpi, AUSL di Modena, Italy.
² Neurology Unit, OCB Hospital, Azienda Ospedaliera Universitaria di Modena, Italy; Department of Biomedical, Metabolic, and Neural Science, University of Modena and Reggio Emilia, Modena Italy; PhD Program in Clinical and Experimental Medicine, University of Modena and Reggio Emilia, Modena, Italy.
³ Intensive Care Unit, OCB Hospital, Azienda Ospedaliera Universitaria di Modena, Italy.
⁴ Neurology Unit, OCB Hospital, Azienda Ospedaliera Universitaria di Modena, Italy; Department of Biomedical, Metabolic, and Neural Science, University of Modena and Reggio Emilia, Modena Italy.
⁵ Diagnostica patologie autoimmuni - Dipartimento Interaziendale ad Attività Integrata di Medicina di Laboratorio ed Anatomia Patologica, Azienda Ospedaliera Universitaria di Modena, Italy.
⁶ Intensive Care Unit, Ospedale Ramazzini di Carpi, AUSL di Modena, Italy.
⁷ Neurology Unit, OCB Hospital, Azienda Ospedaliera Universitaria di Modena, Italy; Department of Biomedical, Metabolic, and Neural Science, University of Modena and Reggio Emilia, Modena Italy. Electronic address: stefano.meletti@unimore.it.

No abstract available

Keywords: Anti-NMDA-R encephalitis; Autoimmune diseases; COVID-19; NORSE; Status epilepticus.

Publication types